Literature DB >> 28555747

Liver X receptors link lipid metabolism and inflammation.

Ira G Schulman1.   

Abstract

The response of immune cells to pathogens is often associated with changes in the flux through basic metabolic pathways. Indeed, in many cases changes in metabolism appear to be necessary for a robust immune response. The Liver X receptors (LXRs) are members of the nuclear hormone receptor superfamily that regulate gene networks controlling cholesterol and lipid metabolism. In immune cells, particularly in macrophages, LXRs also inhibit proinflammatory gene expression. This Review will highlight recent studies that connect LXR-dependent control of lipid metabolism to regulation of the immune response.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  cholesterol; inflammation; lipids; metabolism; nuclear receptors; transcription

Mesh:

Substances:

Year:  2017        PMID: 28555747      PMCID: PMC5638683          DOI: 10.1002/1873-3468.12702

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  112 in total

1.  Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.

Authors:  Eric D Bischoff; Chris L Daige; Mary Petrowski; Harry Dedman; Jennifer Pattison; Joseph Juliano; Andrew C Li; Ira G Schulman
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

2.  Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.

Authors:  Laurent Yvan-Charvet; Mollie Ranalletta; Nan Wang; Seongah Han; Naoki Terasaka; Rong Li; Carrie Welch; Alan R Tall
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

3.  Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils.

Authors:  Todd G Kirchgessner; Paul Sleph; Jacek Ostrowski; John Lupisella; Carol S Ryan; Xiaoqin Liu; Gayani Fernando; Denise Grimm; Petia Shipkova; Rongan Zhang; Ricardo Garcia; Jun Zhu; Aiqing He; Harold Malone; Richard Martin; Kamelia Behnia; Zhaoqing Wang; Yu Chen Barrett; Robert J Garmise; Long Yuan; Jane Zhang; Mohit D Gandhi; Philip Wastall; Tong Li; Shuyan Du; Lisa Salvador; Raju Mohan; Glenn H Cantor; Ellen Kick; John Lee; Robert J A Frost
Journal:  Cell Metab       Date:  2016-08-09       Impact factor: 27.287

4.  Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.

Authors:  Jay Wrobel; Robert Steffan; S Marc Bowen; Ronald Magolda; Edward Matelan; Rayomand Unwalla; Michael Basso; Valerie Clerin; Stephen J Gardell; Ponnal Nambi; Elaine Quinet; Jason I Reminick; George P Vlasuk; Shuguang Wang; Irene Feingold; Christine Huselton; Tomas Bonn; Mathias Farnegardh; Tomas Hansson; Annika Goos Nilsson; Anna Wilhelmsson; Edouard Zamaratski; Mark J Evans
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

5.  Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection.

Authors:  Larisa Dubrovsky; Rachel Van Duyne; Svetlana Senina; Irene Guendel; Tatiana Pushkarsky; Dmitri Sviridov; Fatah Kashanchi; Michael Bukrinsky
Journal:  Biochem Biophys Res Commun       Date:  2012-02-04       Impact factor: 3.575

6.  The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response.

Authors:  Mathieu Blanc; Wei Yuan Hsieh; Kevin A Robertson; Kai A Kropp; Thorsten Forster; Guanghou Shui; Paul Lacaze; Steven Watterson; Samantha J Griffiths; Nathanael J Spann; Anna Meljon; Simon Talbot; Kathiresan Krishnan; Douglas F Covey; Markus R Wenk; Marie Craigon; Zsolts Ruzsics; Jürgen Haas; Ana Angulo; William J Griffiths; Christopher K Glass; Yuqin Wang; Peter Ghazal
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

7.  Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.

Authors:  Yuan Zhang; Sarah R Breevoort; Jerry Angdisen; Mingui Fu; Daniel R Schmidt; Sam R Holmstrom; Steven A Kliewer; David J Mangelsdorf; Ira G Schulman
Journal:  J Clin Invest       Date:  2012-04-09       Impact factor: 14.808

8.  LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.

Authors:  Noam Zelcer; Cynthia Hong; Rima Boyadjian; Peter Tontonoz
Journal:  Science       Date:  2009-06-11       Impact factor: 47.728

9.  Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARgamma-/-, PPARdelta-/-, PPARgammadelta-/-, or LXRalphabeta-/- bone marrow.

Authors:  Chaitra Marathe; Michelle N Bradley; Cynthia Hong; Lily Chao; Damien Wilpitz; Jon Salazar; Peter Tontonoz
Journal:  J Lipid Res       Date:  2008-09-04       Impact factor: 5.922

10.  LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size.

Authors:  Hiroaki Okazaki; Joseph L Goldstein; Michael S Brown; Guosheng Liang
Journal:  J Biol Chem       Date:  2009-12-27       Impact factor: 5.157

View more
  55 in total

1.  Comparative proteomic analysis of SLC13A5 knockdown reveals elevated ketogenesis and enhanced cellular toxic response to chemotherapeutic agents in HepG2 cells.

Authors:  Tao Hu; Weiliang Huang; Zhihui Li; Maureen A Kane; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-04       Impact factor: 4.219

2.  Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes.

Authors:  Cristiano P Vieira; Seth D Fortmann; Masroor Hossain; Ana Leda Longhini; Sandra S Hammer; Bright Asare-Bediako; David K Crossman; Micheli S Sielski; Yvonne Adu-Agyeiwaah; Mariana Dupont; Jason L Floyd; Sergio Li Calzi; Todd Lydic; Robert S Welner; Gary J Blanchard; Julia V Busik; Maria B Grant
Journal:  JCI Insight       Date:  2020-07-09

Review 3.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

4.  Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2-deficient mice following dietary challenge.

Authors:  Elizabeth S Moore; Erin K Daugherity; David I Karambizi; Bethany P Cummings; Erica Behling-Kelly; Deanna M W Schaefer; Teresa L Southard; Joseph W McFadden; Robert S Weiss
Journal:  J Biol Chem       Date:  2019-08-21       Impact factor: 5.157

5.  Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.

Authors:  Ana Ramón-Vázquez; Juan Vladimir de la Rosa; Carlos Tabraue; Felix Lopez; Bonifacio Nicolas Díaz-Chico; Lisardo Bosca; Peter Tontonoz; Susana Alemany; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

6.  ATP binding cassette family A protein 1 determines hexosylceramide and sphingomyelin levels in human and mouse plasma.

Authors:  Jahangir Iqbal; Meghan T Walsh; Samar M Hammad; Marina Cuchel; Daniel J Rader; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2018-10-02       Impact factor: 5.922

7.  Inflammation Triggers Liver X Receptor-Dependent Lipogenesis.

Authors:  Sophie R Liebergall; Jerry Angdisen; Shun Hang Chan; YingJu Chang; Timothy F Osborne; Alexander F Koeppel; Stephen D Turner; Ira G Schulman
Journal:  Mol Cell Biol       Date:  2020-01-03       Impact factor: 4.272

Review 8.  The clearance of dead cells by efferocytosis.

Authors:  Emilio Boada-Romero; Jennifer Martinez; Bradlee L Heckmann; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2020-04-06       Impact factor: 94.444

9.  An increased autophagic flux contributes to the anti-inflammatory potential of urolithin A in macrophages.

Authors:  Yaw Duah Boakye; Laura Groyer; Elke H Heiss
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-10-12       Impact factor: 3.770

Review 10.  Macrophage Efferocytosis in Cardiac Pathophysiology and Repair.

Authors:  Yutian Li; Qianqian Li; Guo-Chang Fan
Journal:  Shock       Date:  2021-02-01       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.